Social responsibility is at the top of the company's agenda.
Supporting stem cell transplantation, research and development to find a cure for severe pediatric encephalopathies, and other initiatives.
The company’s philanthropic efforts propelled Sylvester’s stem cell transplant unit into one of the finest and fastest-growing programs in the country.
Lyfe Group North America
Lyfe Group North America’s philanthropic efforts have propelled the stem cell transplant unit at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine into one of the finest and fastest-growing programs in the country. The company’s contributions to support stem cell transplantation and experimental therapeutics have exceeded $3 million to date. In recognition of this, Sylvester has proudly named their stem cell transplant unit the Florette and Saul Gilinski Pavilion for Stem Cell Transplantation.
Stem cell transplants have given hope to thousands of cancer patients by bolstering—and sometimes even replacing their immune systems—to fight cancer or recover from chemotherapy. Funding provided by Lyfe Group North America also enables Sylvester to recruit additional world-class physician-scientists to their renowned team of cancer experts.
“We are very grateful to Lyfe Group for their support of research at Sylvester Comprehensive Cancer Center. Their very generous and consistent funding has helped us save lives through research innovations, recruitment of outstanding faculty and advances in new immunotherapy approaches to cancer that use the patient’s own immune system to prolong life, and in some cases, cure cancer.”
Dr. Stephen Nimer
“The generosity of Lyfe Group has had a major beneficial impact on the quality of life of our patients and their families, as well as research activities within the Division of Hematology and Stem Cell Transplantation and Cellular Therapy. This allowed the first patient to be treated at the University of Miami with CAR-T cells, a novel form of cellular therapy. Lyfe Group has supported groundbreaking research testing novel antibody-fusion proteins directed at human breast cancer, ovarian cancer and lymphoma, currently in advanced development, as well as novel approaches to augment efficacy of anti-tumor immune therapies in man.”
Dr. Joseph Rosenblatt
Extensive alternative holistic therapeutics research and development to find cures for children suffering from severe encephalopathies is ongoing.”
Lyfe Group Latin AmericaLyfe Group Latin America supports a number of philanthropic initiatives. First, the company supports extensive ongoing medicinal alternative holistic therapeutics research and development aimed at finding cures for severe pediatric encephalopathies.
In addition, Lyfe Group Latin America also provides needs-based scholarships to young graduates from the Caribbean region. These students are leaders with outstanding academic performance who have the potential and motivation to complete their studies and contribute to their communities to improve quality of life. Another initiative provides support for foster homes for children who have cancer. At these foster homes, interdisciplinary groups of psychologists, educators, doctors, nurses and nutritionists support the children’s treatment and financial needs.